emerin and Aging--Premature

emerin has been researched along with Aging--Premature* in 2 studies

Reviews

1 review(s) available for emerin and Aging--Premature

ArticleYear
Emerin and the nuclear lamina in muscle and cardiac disease.
    Circulation research, 2008, Jul-03, Volume: 103, Issue:1

    The human genome is contained within the nucleus and is separated from the cytoplasm by the nuclear envelope. Mutations in the nuclear envelope proteins emerin and lamin A cause a number of diseases including premature aging syndromes, muscular dystrophy, and cardiomyopathy. Emerin and lamin A are implicated in regulating muscle- and heart-specific gene expression and nuclear architecture. For example, lamin A regulates the expression and localization of gap junction and intercalated disc components. Additionally, emerin and lamin A are also required to maintain nuclear envelope integrity. Demonstrating the importance of maintaining nuclear integrity in heart disease, atrioventricular node cells lacking lamin A exhibit increased nuclear deformation and apoptosis. This review highlights the present understanding of lamin A and emerin function in regulating nuclear architecture, gene expression, and cell signaling and discusses putative mechanisms for how specific mutations in lamin A and emerin cause cardiac- or muscle-specific disease.

    Topics: Aging, Premature; Animals; Apoptosis; Atrioventricular Node; Cardiomyopathies; Gene Expression Regulation; Genome, Human; Humans; Lamin Type A; Membrane Proteins; Muscular Dystrophies; Mutation; Myocardium; Nuclear Lamina; Nuclear Proteins; Organ Specificity; Signal Transduction; Syndrome

2008

Other Studies

1 other study(ies) available for emerin and Aging--Premature

ArticleYear
Primary laminopathy fibroblasts display altered genome organization and apoptosis.
    Aging cell, 2007, Volume: 6, Issue:2

    A number of diseases associated with specific tissue degeneration and premature aging have mutations in the nuclear envelope proteins A-type lamins or emerin. Those diseases with A-type lamin mutation are inclusively termed laminopathies. Due to various hypothetical roles of nuclear envelope proteins in genome function we investigated whether alterations to normal genomic behaviour are apparent in cells with mutations in A-type lamins and emerin. Even though the distributions of these proteins in proliferating laminopathy fibroblasts appear normal, there is abnormal nuclear positioning of both chromosome 18 and 13 territories, from the nuclear periphery to the interior. This genomic organization mimics that found in normal nonproliferating quiescent or senescent cells. This finding is supported by distributions of modified pRb in the laminopathy cells. All laminopathy cell lines tested and an X-linked Emery-Dreifuss muscular dystrophy cell line also demonstrate increased incidences of apoptosis. The most extreme cases of apoptosis occur in cells derived from diseases with mutations in the tail region of the LMNA gene, such as Dunningan-type familial partial lipodystrophy and mandibuloacral dysplasia, and this correlates with a significant level of micronucleation in these cells.

    Topics: Aging, Premature; Apoptosis; Cell Line; Cell Proliferation; Fibroblasts; Genome, Human; Humans; Lamin Type A; Lipodystrophy, Familial Partial; Membrane Proteins; Muscular Dystrophy, Emery-Dreifuss; Nuclear Envelope; Nuclear Proteins

2007